282 related articles for article (PubMed ID: 17879145)
21. Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen.
Kölker S; Hoffmann GF; Schor DS; Feyh P; Wagner L; Jeffrey I; Pourfarzam M; Okun JG; Zschocke J; Baric I; Bain MD; Jakobs C; Chalmers RA
Neuropediatrics; 2003 Jun; 34(5):253-60. PubMed ID: 14598231
[TBL] [Abstract][Full Text] [Related]
22. Inherited Disorders of Lysine Metabolism: A Review.
Bouchereau J; Schiff M
J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
[TBL] [Abstract][Full Text] [Related]
23. Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency.
Strauss KA; Donnelly P; Wintermark M
Brain; 2010 Jan; 133(Pt 1):76-92. PubMed ID: 20032085
[TBL] [Abstract][Full Text] [Related]
24. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.
Boy N; Mühlhausen C; Maier EM; Heringer J; Assmann B; Burgard P; Dixon M; Fleissner S; Greenberg CR; Harting I; Hoffmann GF; Karall D; Koeller DM; Krawinkel MB; Okun JG; Opladen T; Posset R; Sahm K; Zschocke J; Kölker S;
J Inherit Metab Dis; 2017 Jan; 40(1):75-101. PubMed ID: 27853989
[TBL] [Abstract][Full Text] [Related]
25. Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).
Kölker S; Christensen E; Leonard JV; Greenberg CR; Burlina AB; Burlina AP; Dixon M; Duran M; Goodman SI; Koeller DM; Müller E; Naughten ER; Neumaier-Probst E; Okun JG; Kyllerman M; Surtees RA; Wilcken B; Hoffmann GF; Burgard P
J Inherit Metab Dis; 2007 Feb; 30(1):5-22. PubMed ID: 17203377
[TBL] [Abstract][Full Text] [Related]
26. Immunolocalization of glutaryl-CoA dehydrogenase (GCDH) in adult and embryonic rat brain and peripheral tissues.
Braissant O; Jafari P; Remacle N; Cudré-Cung HP; Do Vale Pereira S; Ballhausen D
Neuroscience; 2017 Feb; 343():355-363. PubMed ID: 27984186
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
Guerreiro G; Faverzani J; Moura AP; Volfart V; Gome Dos Reis B; Sitta A; Gonzalez EA; de Lima Rosa G; Coitinho AS; Baldo G; Wajner M; Vargas CR
Arch Biochem Biophys; 2021 Sep; 709():108970. PubMed ID: 34181873
[TBL] [Abstract][Full Text] [Related]
28. Deletion of 2-aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1.
Leandro J; Dodatko T; DeVita RJ; Chen H; Stauffer B; Yu C; Houten SM
J Inherit Metab Dis; 2020 Nov; 43(6):1154-1164. PubMed ID: 32567100
[TBL] [Abstract][Full Text] [Related]
29. Adult-onset glutaric aciduria type I: rare presentation of a treatable disorder.
Gelener P; Severino M; Diker S; Teralı K; Tuncel G; Tuzlalı H; Manara E; Paolacci S; Bertelli M; Ergoren MC
Neurogenetics; 2020 Jul; 21(3):179-186. PubMed ID: 32306145
[TBL] [Abstract][Full Text] [Related]
30. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.
Harting I; Neumaier-Probst E; Seitz A; Maier EM; Assmann B; Baric I; Troncoso M; Mühlhausen C; Zschocke J; Boy NP; Hoffmann GF; Garbade SF; Kölker S
Brain; 2009 Jul; 132(Pt 7):1764-82. PubMed ID: 19433437
[TBL] [Abstract][Full Text] [Related]
31. Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.
Seminotti B; Amaral AU; Ribeiro RT; Rodrigues MDN; Colín-González AL; Leipnitz G; Santamaría A; Wajner M
Mol Neurobiol; 2016 Nov; 53(9):6459-6475. PubMed ID: 26607633
[TBL] [Abstract][Full Text] [Related]
32. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular investigation in Chinese patients with glutaric aciduria type I.
Zhang Y; Li H; Ma R; Mei L; Wei X; Liang D; Wu L
Clin Chim Acta; 2016 Jan; 453():75-9. PubMed ID: 26656312
[TBL] [Abstract][Full Text] [Related]
34. Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency.
Strauss KA; Lazovic J; Wintermark M; Morton DH
Brain; 2007 Jul; 130(Pt 7):1905-20. PubMed ID: 17478444
[TBL] [Abstract][Full Text] [Related]
35. Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency.
Gerstner B; Gratopp A; Marcinkowski M; Sifringer M; Obladen M; Bührer C
Pediatr Res; 2005 Jun; 57(6):771-6. PubMed ID: 15774829
[TBL] [Abstract][Full Text] [Related]
36. Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I.
Vendramin Pasquetti M; Meier L; Loureiro S; Ganzella M; Junges B; Barbieri Caus L; Umpierrez Amaral A; Koeller DM; Goodman S; Woontner M; Gomes de Souza DO; Wajner M; Calcagnotto ME
Epilepsia; 2017 Oct; 58(10):1771-1781. PubMed ID: 28762469
[TBL] [Abstract][Full Text] [Related]
37. GAI - distinct genotype and phenotype characteristics in reported Slovak patients.
Lisyova J; Petrovic R; Jurickova K; Brennerova K; Urbanova D; Behulova D; Bzduch V; Chandoga J
Bratisl Lek Listy; 2016; 117(11):631-638. PubMed ID: 28125888
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a synergistic action of glutaric and 3-hydroxyglutaric acids disturbing rat brain energy metabolism.
Ferreira GC; Tonin A; Schuck PF; Viegas CM; Ceolato PC; Latini A; Perry ML; Wyse AT; Dutra-Filho CS; Wannmacher CM; Vargas CR; Wajner M
Int J Dev Neurosci; 2007 Oct; 25(6):391-8. PubMed ID: 17643899
[TBL] [Abstract][Full Text] [Related]
39. Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.
Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Vargas CR; Leipnitz G; Santamaría A; Souza DO; Wajner M
Neurotox Res; 2018 Apr; 33(3):593-606. PubMed ID: 29235064
[TBL] [Abstract][Full Text] [Related]
40. Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency.
Külkens S; Harting I; Sauer S; Zschocke J; Hoffmann GF; Gruber S; Bodamer OA; Kölker S
Neurology; 2005 Jun; 64(12):2142-4. PubMed ID: 15985591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
